Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma
Andrea Rinaldi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Francesco Bertoni(Ente Ospedaliero Cantonale), Monica Taborelli(Institute of Oncology Research), Gianluca Gaïdano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Giulia Poretti(Institute of Oncology Research), Cristina Largo(Centro Nacional de Epidemiología), Luca Baldini(University of Milan), Giovanni Martinelli(University of Bologna), Giancarlo Pruneri(University of Milan), Ivo Kwee(Dalle Molle Institute for Artificial Intelligence Research), Carlo V. Catapano(Institute of Oncology Research), Giuseppe Calabrese(University of Chieti-Pescara), Emanuele Zucca(Università della Svizzera italiana), Carlo Capella(University of Insubria), Vittoria Martin(University of Insubria), Maria Grazia Tibiletti(University of Insubria), Silvia Uccella(University of Insubria), Finbarr E. Cotter(Queen Mary University of London), Juan C. Cigudosa(Centro Nacional de Epidemiología)
Cited by 193
Related Papers
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
|Genetics in Medicine|2019|666
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644